Evaluation of Baricitinib Administration for Atopic Dermatitis Patients in Spain: Insights from the DAMA-S Retrospective Chart Analysis - Poll - MDSpire

Evaluation of Baricitinib Administration for Atopic Dermatitis Patients in Spain: Insights from the DAMA-S Retrospective Chart Analysis

  • By

  • Enrique Gómez de la Fuente

  • Enrique Herrera

  • Iñigo Martinez-Espronceda Esquerdo

  • David Vidal Sarró

  • Ignasi Figueras-Nart

  • Juan F. Silvestre Salvador

  • Yolanda Gilaberte

  • Sergio Santos Alarcón

  • Esther Serra-Baldrich

  • Monica Munera Campos

  • Rosa M. Moro

  • Silvia Díaz-Cerezo

  • Sebastian Moyano

  • Irene Talavera-Rodríguez

  • Mercedes Núñez

  • April 21, 2026

  • 0 min

Share

Original Source(s)

Evaluation of Baricitinib Administration for Atopic Dermatitis Patients in Spain: Insights from the DAMA-S Retrospective Chart Analysis

  • by Enrique Gómez de la Fuente, Enrique Herrera, Iñigo Martinez-Espronceda Esquerdo, David Vidal Sarró, Ignasi Figueras-Nart, Juan F. Silvestre Salvador, Yolanda Gilaberte, Sergio Santos Alarcón, Esther Serra-Baldrich, Monica Munera Campos, Rosa M. Moro, Silvia Díaz-Cerezo, Sebastian Moyano, Irene Talavera-Rodríguez, Mercedes Núñez

  • April 21, 2026

Related Content

Extended Safety and Effectiveness of Tralokinumab in Individuals with Moderate-to-Severe Atopic Dermatitis Over a 6-Year Period: Final Outcomes from the ECZTEND Open-Label Extension Study

Evaluating Itch in Atopic Dermatitis: Perspectives from UK Dermatologists Through a Cross-Sectional Survey and Narrative Review

Minimal Systemic Exposure with Maximal Delgocitinib Cream Use in Patients with Severe Chronic Hand Eczema in the DELTA 2 Randomized, Vehicle-Controlled, Double-Blind, Phase 3 Trial